Export 90 results:
Author Title [ Type(Asc)] Year
Filters: Author is Cruz, F.  [Clear All Filters]
Journal Article
Frias, B., Santos, J., Morgado, M., Sousa, M. M., et al. (2015). The role of brain-derived neurotrophic factor (BDNF) in the development of neurogenic detrusor overactivity (NDO). Journal of Neuroscience, 35(5), 2146 - 2160.
Cruz, F., & Dinis, P. (2007). Resiniferatoxin and botulinum toxin type A for treatment of lower urinary tract symptoms. Neurourology and Urodynamics, 26(6 SUPPL.), 920 - 927.
Cruz, F., Silva, J., Pinto, R., Carvallho, T., et al. (2009). Reply to Tomasz Drewa, Zbigniew Wolski and Janusz Tyloch's Letter to the Editor re: João Silva, Rui Pinto, Tiago Carvallho, et al. Mechanisms of Prostate Atrophy after Glandular Botulinum Neurotoxin Type A Injection: An Experimental Study in the Rat. Eur. European Urology, 56(5), e28 - e29.
Coelho, A., Cruz, F., Cruz, C. D., & Avelino, A. (2012). Reply from Authors re: Prokar Dasgupta. Volume matters: Bladder injections of botulinum toxin type A. Eur Urol 2012;61:1185-6: Yes, Volume matters: Bladder injections of botulinum toxin type A. European Urology, 61(6), 1186 - 1187.
Oliveira, R., Botelho, F., Silva, P., Resende, A., et al. (2011). Reply from authors re: Elisabetta costantini and massimo lazzeri. Surgery for stress urinary incontinence: So near and yet so far. Eur Urol 2011;59:945-6. European Urology, 59(6), 947.
Cruz, F. (2016). Re: Efficacy and Safety of Mirabegron Add-on Therapy to Solifenacin in Incontinent Overactive Bladder Patients with an Inadequate Response to Initial 4-week Solifenacin Monotherapy: A Randomised Double-blind Multicentre Phase 3B Study (BESIDE). European Urology, 70(5), 892.
Santos-Silva, A., Charrua, A., Cruz, C. D., Gharat, L., et al. (2012). Rat detrusor overactivity induced by chronic spinalization can be abolished by a transient receptor potential vanilloid 1 (TRPV1) antagonist. Autonomic Neuroscience: Basic and Clinical, 166(1-2), 35 - 38.
Andersson, K. - E., Chapple, C. R., Cardozo, L., Cruz, F., et al. (2009). Pharmacological treatment of overactive bladder: Report from the International Consultation on Incontinence. Current Opinion in Urology, 19(4), 380 - 394.
Pinto, R., Lopes, T., Silva, J., Silva, C., et al. (2013). Persistent therapeutic effect of repeated injections of onabotulinum toxin A in refractory bladder pain syndrome/interstitial cystitis. Journal of Urology, 189(2), 548 - 553.
Dickson, A., Avelino, A., Cruz, F., & Ribeiro-da-Silva, A. (2006). Peptidergic sensory and parasympathetic fiber sprouting in the mucosa of the rat urinary bladder in a chronic model of cyclophosphamide-induced cystitis. Neuroscience, 139(2), 671 - 685.
Dickson, A., Avelino, A., Cruz, F., & Ribeiro-da-Silva, A. (2006). Peptidergic sensory and parasympathetic fiber sprouting in the mucosa of the rat urinary bladder in a chronic model of cyclophosphamide-induced cystitis (DOI:10.1016/j.neuroscience.2005.11.050). Neuroscience, 141(3), 1633 - 1647.
Cruz, F., & Desgrandchamps, F. (2010). New Concepts and Pathophysiology of Lower Urinary Tract Symptoms in Men. European Urology, Supplements, 9(4), 472 - 476.
Baiou, D., Santha, P., Avelino, A., Charrua, A., et al. (2007). Neurochemical characterization of insulin receptor-expressing primary sensory neurons in wild-type and vanilloid type 1 transient receptor potential receptor knockout mice. Journal of Comparative Neurology, 503(2), 334 - 347.
Ferreira, S. G., Lomaglio, T., Avelino, A., Cruz, F., et al. (2009). N-acyldopamines control striatal input terminals via novel ligand-gated cation channels. Neuropharmacology, 56(3), 676 - 683.
Athanasopoulos, A., & Cruz, F. (2011). The medical treatment of overactive bladder, including current and future treatments. Expert Opinion on Pharmacotherapy, 12(7), 1041 - 1055.
Silva, J., Pinto, R., Carvallho, T., Coelho, A., et al. (2009). Mechanisms of Prostate Atrophy after Glandular Botulinum Neurotoxin Type A Injection: An Experimental Study in the Rat. European Urology, 56(1), 134 - 141.
Cruz, F. (2004). Mechanisms involved in new therapies for overactive bladder. Urology, 63(3 SUPPL. 1), 65 - 73.
Dinis, P., Charrua, A., Avelino, A., & Cruz, F. (2004). Intravesical resiniferatoxin decreases spinal c-fos expression and increases bladder volume to reflex micturition in rats with chronic inflamed urinary bladders. BJU International, 94(1), 153 - 157.
Cruz, C. D., Charrua, A., Vieira, E., Valente, J., et al. (2008). Intrathecal delivery of resiniferatoxin (RTX) reduces detrusor overactivity and spinal expression of TRPV1 in spinal cord injured animals. Experimental Neurology, 214(2), 301 - 308.
Silva, J., Pinto, R., Carvalho, T., Botelho, F., et al. (2009). Intraprostatic Botulinum Toxin Type A injection in patients with benign prostatic enlargement: Duration of the effect of a single treatment. BMC Urology, 9(1).
Silva, J., Silva, C., Saraiva, L., Silva, A., et al. (2008). Intraprostatic Botulinum Toxin Type A Injection in Patients Unfit for Surgery Presenting with Refractory Urinary Retention and Benign Prostatic Enlargement. Effect on Prostate Volume and Micturition Resumption. European Urology, 53(1), 153 - 159.
Silva, J., Pinto, R., Carvalho, T., Botelho, F., et al. (2011). Intraprostatic botulinum toxin type A administration: Evaluation of the effects on sexual function. BJU International, 107(12), 1950 - 1954.
Guimarães, M., Oliveira, R., Pinto, R., Soares, A., et al. (2009). Intermediate-term results, up to 4 years, of a bone-anchored male perineal sling for treating male stress urinary incontinence after prostate surgery. BJU International, 103(4), 500 - 504.
Cruz, C. D., Neto, F. L., Castro-Lopes, J., McMahon, S. B., & Cruz, F. (2005). Inhibition of ERK phosphorylation decreases nociceptive behaviour in monoarthritic rats. Pain, 116(3), 411 - 419.
Cruz, C. D., Avelino, A., McMahon, S. B., & Cruz, F. (2005). Increased spinal cord phosphorylation of extracellular signal-regulated kinases mediates micturition overactivity in rats with chronic bladder inflammation. European Journal of Neuroscience, 21(3), 773 - 781.

Pages


Home | Site Map | Contacts | Credits | Privacy & Cookies | Intranet | Social Networks |


rua alfredo allen, 208, 4200-135 porto - portugal | tel +351 220 408 800 | email: info@i3s.up.pt | © copyright 2010 ibmc